Russell Investments Group Ltd. Decreases Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
New York State Common Retirement Fund lessened its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 214,396 shares of the company’s stock after selling 29,456 shares during the period. New York State Common […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 5,000 shares of the stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $22.82, for a total transaction of $114,100.00. Following the completion of the sale, the director now owns 14,830 shares […]
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are currently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation and sixteen have issued a buy recommendation on the company. The average […]
Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$1.69 and last traded at C$1.69, with a volume of 501 shares traded. The stock had previously closed at C$1.75. Aptose Biosciences Stock Down 3.4 % The stock has […]